Feed / ONC

BeOne Medicines AG

ONC

Healthcare · 374.79 +1.6% today

Isolated · not yet confirmedMarket checked 21 Aug, 15:55 GMT-4

Jodie situation report

BeOne Medicines AG's current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 15 directly disclosed connections are confirming.

Company+1.6% todayVolume comparison unavailable
Market group0 of 1 activeOncology Drug Developers · unavailable
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • Monitor disclosures attributing changes in interest expense to the sale of future royalty liability, higher debt rates, or changes in capitalized interest at Hopewell.

Invalidation: The isolated read changes if ONC's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind ONC

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

AMGNAmgen Inc.partnerFeb 26, 2026

We will share in a portion of the royalties on annual ex-China net revenue from IMDELLTRA ® above $1.5 billion, and will maintain royalty and all other rights to other assets under the terms of the existing collaboration with Amgen, including xaluritamig, a f…

AMGNAmgen Inc.supplierAug 6, 2025

Purchase Commitments As of June 30, 2025, non-cancellable purchase commitments amounted to $130.1 million, of which $32.6 million related to minimum purchase requirements for supply purchased from contract manufacturers and $97.5 million related to binding pu…

Depended on by

ZYMEZymeworks Inc.partnerMay 7, 2026

We have entered into separate collaboration and license agreements with BeOne Medicines Ltd.

Filing peers

No filing peers are available for this name yet.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 12 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

ONC is currently a Leader in the organic co-movement group Oncology Drug Developers. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for ONC; it is not active in the latest market snapshot.